ERBB2 and neoplasm: Treatment with suppressor cells with the synNotch→TGFβ1+CD25 circuit reduced accumulation of both anti-Her2 CD4+ and CD8+ CAR T cells in the dual-antigen tumor at day 14 (Fig. 3C).